JP2011500693A5 - - Google Patents

Download PDF

Info

Publication number
JP2011500693A5
JP2011500693A5 JP2010530049A JP2010530049A JP2011500693A5 JP 2011500693 A5 JP2011500693 A5 JP 2011500693A5 JP 2010530049 A JP2010530049 A JP 2010530049A JP 2010530049 A JP2010530049 A JP 2010530049A JP 2011500693 A5 JP2011500693 A5 JP 2011500693A5
Authority
JP
Japan
Prior art keywords
methyl
bipyrrolidinyl
phenyl
amide
carboxylic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2010530049A
Other languages
English (en)
Japanese (ja)
Other versions
JP5377503B2 (ja
JP2011500693A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2008/079757 external-priority patent/WO2009052062A1/en
Publication of JP2011500693A publication Critical patent/JP2011500693A/ja
Publication of JP2011500693A5 publication Critical patent/JP2011500693A5/ja
Application granted granted Critical
Publication of JP5377503B2 publication Critical patent/JP5377503B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2010530049A 2007-10-17 2008-10-14 置換されたn−フェニル−ビピロリジンカルボキサミド及びその治療上の使用 Expired - Fee Related JP5377503B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US98059907P 2007-10-17 2007-10-17
US60/980,599 2007-10-17
PCT/US2008/079757 WO2009052062A1 (en) 2007-10-17 2008-10-14 Substituted n-phenyl-bipyrrolidine carboxamides and therapeutic use thereof

Publications (3)

Publication Number Publication Date
JP2011500693A JP2011500693A (ja) 2011-01-06
JP2011500693A5 true JP2011500693A5 (enExample) 2011-12-01
JP5377503B2 JP5377503B2 (ja) 2013-12-25

Family

ID=40247942

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010530049A Expired - Fee Related JP5377503B2 (ja) 2007-10-17 2008-10-14 置換されたn−フェニル−ビピロリジンカルボキサミド及びその治療上の使用

Country Status (25)

Country Link
US (2) US8088808B2 (enExample)
EP (1) EP2212283B1 (enExample)
JP (1) JP5377503B2 (enExample)
KR (1) KR20100072077A (enExample)
CN (1) CN101903340B (enExample)
AT (1) ATE525351T1 (enExample)
AU (1) AU2008312635B2 (enExample)
BR (1) BRPI0818581A2 (enExample)
CA (1) CA2702467C (enExample)
CY (1) CY1112083T1 (enExample)
DK (1) DK2212283T3 (enExample)
ES (1) ES2372332T3 (enExample)
HR (1) HRP20110762T1 (enExample)
IL (1) IL205001A (enExample)
MA (1) MA31858B1 (enExample)
MX (1) MX2010003949A (enExample)
MY (1) MY151348A (enExample)
NZ (1) NZ584690A (enExample)
PL (1) PL2212283T3 (enExample)
PT (1) PT2212283E (enExample)
RS (1) RS52235B (enExample)
RU (1) RU2477720C2 (enExample)
SI (1) SI2212283T1 (enExample)
WO (1) WO2009052062A1 (enExample)
ZA (1) ZA201002115B (enExample)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2702834C (en) 2007-10-17 2013-01-15 Sanofi-Aventis Substituted n-phenyl-pyrrolidinylmethylpyrrolidine amides and therapeutic use thereof
CN101903341B (zh) 2007-10-17 2012-10-03 赛诺菲-安万特 取代的n-苯基-联吡咯烷脲及其治疗用途
MY151348A (en) * 2007-10-17 2014-05-15 Sanofi Aventis Substituted n-phenyl-bipyrrolidine carboxamides and therapeutic use thereof
AU2008312638B2 (en) * 2007-10-17 2013-05-16 Sanofi-Aventis Substituted N-phenyl-bipyrrolidine carboxamides and therapeutic use thereof
AR074467A1 (es) 2008-12-05 2011-01-19 Sanofi Aventis Tetrahidropiran espiro pirrolidinonas y piperidinonas sustituidas, composiciones farmaceuticas que las contienen y uso de las mismas en el tratamiento y/o prevencion de enfermedades del snc ,tales como alzheimer y parkinson, entre otras.
AR074466A1 (es) 2008-12-05 2011-01-19 Sanofi Aventis Piperidina espiro pirrolidinona y piperidinona sustituidas y su uso terapeutico en enfermedades mediadas por la modulacion de los receptores h3.
SA110310332B1 (ar) * 2009-05-01 2013-12-10 Astrazeneca Ab مركبات ميثانون (3 استبدال -ازيتيدين -1-يل )(5- فينيل -1، 3، 4- أوكساديازول -2-يل )
EP2569303A1 (en) 2010-05-11 2013-03-20 Sanofi Substituted n-alkyl and n-acyl tetrahydro-isoquinoline derivatives, preparation and therapeutic use thereof
JP2013529198A (ja) 2010-05-11 2013-07-18 サノフイ 置換されたn−ヘテロシクロアルキルビピロリジニルフェニルアミド誘導体、その製造及び治療上の使用
TW201202251A (en) * 2010-05-11 2012-01-16 Sanofi Aventis Substituted N-heteroaryl spirolactam bipyrrolidines, preparation and therapeutic use thereof
TW201206939A (en) 2010-05-11 2012-02-16 Sanofi Aventis Substituted phenyl cycloalkyl pyrrolidine (piperidine) spirolactams and amides, preparation and therapeutic use thereof
EP2569296A1 (en) * 2010-05-11 2013-03-20 Sanofi Substituted n-phenyl spirolactam bipyrrolidines, preparation and therapeutic use thereof
AR081383A1 (es) 2010-05-11 2012-08-29 Sanofi Aventis N-heteroaril bipirrolidin carboxamidas sustituidas, composiciones farmaceuticas que las contienen y uso de las mismas para el tratamiento de enfermedades del sistema nervioso central.
JP5784110B2 (ja) 2010-05-11 2015-09-24 サノフイ 置換されたn−ヘテロアリールテトラヒドロ−イソキノリン誘導体、その製造及び治療上の使用
MX2012015102A (es) * 2010-07-06 2013-05-01 Astrazeneca Ab Agentes terapeuticos 976.
UY34194A (es) 2011-07-15 2013-02-28 Astrazeneca Ab ?(3-(4-(espiroheterocíclico)metil)fenoxi)azetidin-1-il)(5-(fenil)-1,3,4-oxadiazol-2-il)metanona en el tratamiento de la obesidad?
JP2013232564A (ja) * 2012-04-27 2013-11-14 National Institute Of Advanced Industrial & Technology 半導体装置および半導体装置の製造方法
CN108250128A (zh) * 2012-09-27 2018-07-06 江苏先声药业有限公司 作为钾通道调节剂的化合物
EP2943196A1 (en) 2013-01-10 2015-11-18 Grünenthal GmbH Pyrazolyl-based carboxamides i as crac channel inhibitors
EP2943197A1 (en) 2013-01-10 2015-11-18 Grünenthal GmbH Pyrazolyl-based carboxamides ii as crac channel inhibitors
EP3366683A1 (en) 2017-02-28 2018-08-29 Acousia Therapeutics GmbH Cyclic amides, acteamides and ureas useful as potassium channel openers

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20020507A1 (es) * 2000-10-17 2002-06-25 Schering Corp Compuestos no-imidazoles como antagonistas del receptor histamina h3
EP1556046A1 (en) * 2002-10-23 2005-07-27 Janssen Pharmaceutica N.V. Phenylpiperidines and phenylpyrrolidines as histamine h3 receptor modulators
US7223788B2 (en) * 2003-02-14 2007-05-29 Sanofi-Aventis Deutschland Gmbh Substituted N-aryl heterocycles, process for their preparation and their use as medicaments
DE10306250A1 (de) * 2003-02-14 2004-09-09 Aventis Pharma Deutschland Gmbh Substituierte N-Arylheterozyklen, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
ES2335305T3 (es) 2005-03-17 2010-03-24 Eli Lilly And Company Derivados de pirrolidina como antagonistas del receptor h3 de histamina.
WO2006107661A1 (en) * 2005-04-01 2006-10-12 Eli Lilly And Company Histamine h3 receptor agents, preparation and therapeutic uses
MX2007016216A (es) * 2005-07-01 2008-03-11 Lilly Co Eli Agenes del receptor de histamina h3, preparacion y usos terapeuticos.
AU2006308167A1 (en) * 2005-10-27 2007-05-03 Ucb Pharma, S.A. Compounds comprising a lactam or a lactam derivative moiety, processes for making them, and their uses
AU2007214709A1 (en) * 2006-02-15 2007-08-23 Sanofi-Aventis Azacyclyl-substituted aryldihydroisoquinolinones, process for their preparation and their use as medicaments
CA2702834C (en) 2007-10-17 2013-01-15 Sanofi-Aventis Substituted n-phenyl-pyrrolidinylmethylpyrrolidine amides and therapeutic use thereof
CN101903341B (zh) 2007-10-17 2012-10-03 赛诺菲-安万特 取代的n-苯基-联吡咯烷脲及其治疗用途
AU2008312638B2 (en) * 2007-10-17 2013-05-16 Sanofi-Aventis Substituted N-phenyl-bipyrrolidine carboxamides and therapeutic use thereof
MY151348A (en) * 2007-10-17 2014-05-15 Sanofi Aventis Substituted n-phenyl-bipyrrolidine carboxamides and therapeutic use thereof

Similar Documents

Publication Publication Date Title
CA2702467A1 (en) Substituted n-phenyl-bipyrrolidine carboxamides and therapeutic use thereof
CA2702482A1 (en) Substituted n-phenyl-bipyrrolidine carboxamides and therapeutic use thereof
RU2010119530A (ru) Замещенные n-фенилпирролидинилметилпирролидинамиды и их терапевтическое применение в качестве модуляторов рецептора н3 гистамина
JP2011500697A5 (enExample)
RU2462456C2 (ru) Производные пиразола в качестве ингибиторов 11-бета-hsd1
JP2013518881A5 (enExample)
JP2011500694A5 (enExample)
JP2005527579A5 (enExample)
CA2702933A1 (en) Substituted n-phenyl-bipyrrolidine ureas and therapeutic use thereof
RU2011137454A (ru) Агонисты и антагонисты s1p5-рецепторов и способы их применения
CN109503625A (zh) 一种多环吡啶酮化合物及其药物组合和用途
JP2002539206A5 (enExample)
JP2007508358A5 (enExample)
JP2006522126A5 (enExample)
JP2012515724A5 (enExample)
JP2009541216A5 (enExample)
JP2012507538A5 (enExample)
JP2007508360A5 (enExample)
JP2011528658A5 (enExample)
JP2020527175A5 (enExample)
JP2011527333A5 (enExample)
JP2019525939A5 (enExample)
JP2010510232A5 (enExample)
RU2015131139A (ru) Галогензамещенное гетероциклическое соединение
JP2009510097A5 (enExample)